Call Us : +603-9010-3058
Email Us : This email address is being protected from spambots. You need JavaScript enabled to view it.

Tuesday26 March 2019

The Star : HITV in fight against cancer


This innovation in cancer treatment is relatively new, but the results have been encouraging, and trials at the UKM Medical Centre using HITV to fight cancer are in progress.

A FORM of immunotherapy is showing encouraging results in the treatment of stage 4 and recurrent cancer patients.

In a public forum held last Sunday at the Kuala Lumpur Convention Centre, Dr Kenichiro Hasumi, founder of Hasumi International Research Foundation and innovator of the Hasumi Immuno-Therapeutic Vaccine (HITV), shared his clinical findings on the effects of HITV on patients with stage 4 or recurrent cancer.

Read more ...


HITV Lab is involved in cell-based biotechnology medical applications with special focus on Dendritic Cell-Based Immunotherapy for cancer. HITV Lab is committed to support an international collaboration in the FDA clinical trial of HITV Therapy in late-stage cancer patients led by the University of Maryland, USA.

FacebookTwitterGoogle Bookmarks